MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ero.2025.07.003

Медицинская библиотека · EULAR rheumatology open · 2025

The distinct phenotype of subclinical giant cell arteritis in polymyalgia rheumatica: evidence from a PMR fast-track clinic.

Cowley Sharon, Harkins Patricia, Kirby Colm, Conway Richard, Kane David

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

To define the prevalence and phenotype of subclinical giant cell arteritis (sGCA) in newly diagnosed polymyalgia rheumatica (PMR).

METHODS

This prospective study assessed consecutive patients referred from primary care to a fast-track clinic (FTC) with suspected PMR without GCA features. Patients were compared with a control population which consisted of newly diagnosed, consecutive patients with GCA from an FTC. Assessment included temporal and axillary artery ultrasound and quantitative scoring using Halo count (HC), Halo score (HS), and OMERACT GCA Ultrasound Score (OGUS). Patients with PMR with positive vascular ultrasound findings were diagnosed as sGCA. Cardiovascular risk (American College of Cardiology/American Heart Association Atherosclerotic Cardiovascular disease [ASCVD] score) was calculated.

RESULTS

Seventy-three new PMR and 24 new patients with GCA were included. Twenty-five percent of patients with PMR had ultrasound-confirmed sGCA. Although predominantly male (80% vs 45%), sGCA could not be otherwise clinically differentiated. PMR with sGCA had more extracranial involvement than GCA (47% vs 33%) with lower baseline OGUS scores (0.81 [±0.17] vs 0.96 [±0.21], P = .02). Patients with sGCA relapsed earlier than PMR or GCA. An initial decline in sGCA ultrasound scores was followed by a significant increase. Ultrasound scores in sGCA were independent of cardiovascular risk (ASCVD score).

CONCLUSIONS

This study found that 1 in 5 patients with PMR referred from primary care via an FTC have sGCA. sGCA has a distinct ultrasound phenotype from GCA, with lower vessel wall inflammation quantified by the OGUS, than observed in GCA. A higher clinical and ultrasound relapse rate in patients with sGCA may support closer monitoring and intensive treatment of these patients.

Для цитирования: Cowley Sharon, Harkins Patricia, Kirby Colm, Conway Richard, Kane David. The distinct phenotype of subclinical giant cell arteritis in polymyalgia rheumatica: evidence from a PMR fast-track clinic.. EULAR rheumatology open. 2025. DOI: 10.1016/j.ero.2025.07.003.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.